Anorexia in cancer patients: Prevalence and impact on the nutritional status.

Anorexia in cancer patients: Prevalence and impact on the nutritional status. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Anorexia in cancer patients: Prevalence and impact on the nutritional status. Abstract Text:

F Bozzetti,E Agradi,E Ravera,

One hundred and eightysix cancer patients with different types, site and stage of disease, consecutively admitted to the Istituto Nazionale Tumori, Milan, were examined. The purpose of the study was to assess the prevalence of subjective anorexia and to determine whether some nutrition-related indices are different within homogeneous categories of cancer patients, anorectic and non-anorectic. Anorexia was measured on the basis of an appetite score, evaluated with a visual analogue rating scale. Nutritional intake was evaluated by a computerised programme of the habitual food consumption. Nutritional assessment included anthropometric evaluations (triceps skinfold, arm circumference, arm muscle circumference) and biochemical indices (serum albumin, and total iron binding capacity). A nutritional index was then calculated: GNS = P + I + M x 100, where P: actual weight/premorbid weight; I: actual weight/ideal weight; M: actual arm muscle mass circumference/ideal arm muscle mass circumference. The evaluation of the data showed that: (1) The prevalence of subjective anorexia ranged from 1 3 to 2 5 of the patients depending on the type and site of tumour, and stage of disease. (2) Most of the nutritional-related variables were significantly worse in anorectic compared with non-anorectic patients. (3) Within groups of patients with different tumour location, but homogeneous for the presence or absence of subjective anorexia, there is no difference with respect to nutritional indices; except for patients with cancer of the oesophagus and stomach who were always more depleted. (4) Anorexia did not seem to influence the nutritional status in patients with cancer at an early stage (except in cancer of oesophagus and stomach) but it was associated to malnutrition as the disease progressed to more advanced stages.

Anorexia in cancer patients: Prevalence and impact on the nutritional status. Publishing Authors By Initials

F Bozzetti,E Agradi,E Ravera,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Anorexia in cancer patients: Prevalence and impact on the nutritional status. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical nutrition (Edinburgh, Scotland)

VOLUME: 8

Page Numbers: 35-43

Journal Abbreviation:

ISSN: 0261-5614

DAY: 13

MONTH: Feb

YEAR: 1989

Anorexia in cancer patients: Prevalence and impact on the nutritional status. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8309603

Anorexia in cancer patients: Prevalence and impact on the nutritional status. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Anorexia in cancer patients: Prevalence and impact on the nutritional status. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Anorexia in cancer patients: Prevalence and impact on the nutritional status.

AFFILIATION: Istituto Nazionale Tumori, via Venezian I, 20133 Milano, Italy.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Nutr

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anorexia in cancer patients: Prevalence and impact on the nutritional status Related Publications

• A 4- to 6-year retrospective clinical study of cracked teeth restored with bonded indirect resin composite onlays.
• Anorexia in cancer patients: Prevalence and impact on the nutritional status.
• Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy.
• [A new coumarin derivative anticoagulant: sintrom (G 23350); clinical & experimental researches.]
• [Anticoagulant therapy in cardiovascular diseases.]
• [Arterial hypertension caused by primary malignant adrenocortical tumor.]
• [Behavior of eosinophils and of 17-ketosteroid and 11-oxycortico-steroids und influence of small and large doses of penicillin.]
• [Behavior of prothrombin factors during treatment with anticoagulants of the coumarin & indandione series.]
• [Elimination of uropepsin in normal subjects of both sexes.]
• [Elimination of uropepsin in patients of various diseases.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Our experience with anticoagulant therapy.]